tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher Liu, 7 are a BUY (100%).
Analyst Christopher Liu, currently employed at LEERINK, carries an average stock price target met ratio of 16.67% that have a potential upside of 30.2% achieved within 23 days.
Christopher Liu’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on COGT, Cogent Biosciences at 10-Jun-2022.
Analyst best performing recommendations are on COGT (COGENT BIOSCIENCES).
The best stock recommendation documented was for COGT (COGENT BIOSCIENCES) at 6/10/2022. The price target of $15 was fulfilled within 68 days with a profit of $7.13 (90.6%) receiving and performance score of 13.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$21
$12.01 (133.59%)
$19
7 days ago
(14-Nov-2024)
0/4 (0%)
$11.01 (110.21%)
Buy
$15
$6.01 (66.85%)
$16
8 days ago
(13-Nov-2024)
0/18 (0%)
$4.14 (38.12%)
Buy
$17
$8.01 (89.10%)
$17
17 days ago
(04-Nov-2024)
0/8 (0%)
$5.37 (46.17%)
Buy
$15
$6.01 (66.85%)
$13
1 months 28 days ago
(24-Sep-2024)
1/3 (33.33%)
$4.23 (39.28%)
209
Hold
$10
$1.01 (11.23%)
$8
2 months 16 days ago
(05-Sep-2024)
2/4 (50%)
$-1.48 (-12.89%)
74
What Year was the first public recommendation made by Christopher Liu?
